Log in
NYSE:ABT

Abbott Laboratories Short Interest Ratio and Short Volume

$105.93
-2.43 (-2.24 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$104.75
Now: $105.93
$109.00
50-Day Range
$100.92
MA: $106.43
$111.05
52-Week Range
$61.61
Now: $105.93
$114.19
Volume5.71 million shs
Average Volume7.14 million shs
Market Capitalization$187.55 billion
P/E Ratio61.23
Dividend Yield1.33%
Beta0.92

Short Interest

Abbott Laboratories (NYSE:ABT) Short Interest Data

Current Short Volume:9,440,000 shares
Previous Short Volume:8,680,000 shares
Change Vs. Previous Month:+8.76%
Dollar Volume Sold Short:$1.02 billion
Short Interest Ratio / Days to Cover:2.0
Last Record Date:September, 30 2020
Outstanding Shares:1,760,000,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:5,711,412 shares
Average Trading Volume:7,144,816 shares
Today's Volume Vs. Average:-20.06%



Abbott Laboratories (NYSE:ABT) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/30/20209,440,000 $1.02 billion 8.8%0.0%1.8$108.37
9/15/20208,680,000 $897.95 million -16.5%0.0%1.6$103.45
8/31/202010,400,000 $1.09 billion 3.1%0.0%1.9$105.12
8/14/202010,090,000 $1.08 billion -20.6%0.0%2$106.55
7/31/202012,710,000 $1.28 billion 25.0%0.0%2.2$100.63
7/15/202010,170,000 $1.02 billion -6.7%0.6%1.6$100.64
6/30/202010,900,000 $1.08 billion -15.0%0.0%1.4$98.95
6/15/202012,820,000 $1.18 billion -13.7%0.0%1.4$91.76
5/29/202014,860,000 $1.30 billion -18.0%0.0%1.4$87.30
5/15/202018,120,000 $1.72 billion -7.4%0.0%1.6$94.92
4/30/202019,570,000 $1.78 billion -8.8%1.1%1.9$90.76
4/15/202021,450,000 $2.06 billion 20.7%1.2%2.1$96.07
3/31/202017,770,000 $1.67 billion -22.9%1.0%2$94.06
3/13/202023,053,500 $1.98 billion 21.5%1.3%4.2$86.04
2/28/202018,970,000 $1.19 billion 3.7%1.1%3.4$62.82
2/14/202018,300,000 $1.48 billion 0.8%1.1%3.8$80.88
1/31/202018,160,000 $1.48 billion -12.9%0.0%3.9$81.36
1/15/202020,850,000 $1.86 billion 3.4%1.2%4.3$89.17
12/31/201920,160,000 $1.82 billion 4.4%1.2%4.3$90.40

Abbott Laboratories (NYSE:ABT) Short Interest FAQ

speech bubbles
speech bubbles











What is Abbott Laboratories' current short interest?

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 9,440,000 shares of ABT short. 0.00% of Abbott Laboratories' shares are currently sold short. View details.

What is a good short interest ratio for Abbott Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Abbott Laboratories currently has a short interest ratio of 2.0.

Is Abbott Laboratories' short interest increasing or decreasing?

Abbott Laboratories saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 9,440,000 shares, an increase of 8.8% from the previous total of 8,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Abbott Laboratories' short interest compare to its competitors?

0.00% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "health care equipment" compare to Abbott Laboratories: Medtronic plc (0.00%), Intuitive Surgical, Inc. (0.00%), Becton, Dickinson and Company (0.00%), Boston Scientific Co. (0.00%), Edwards Lifesciences Co. (0.00%), Baxter International Inc. (0.88%), DexCom, Inc. (0.00%), IDEXX Laboratories, Inc. (1.49%), ResMed Inc. (0.00%), and Hologic, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.12 billion), Aon PLC ($3.76 billion), Clorox Co ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), Kroger Co ($2.20 billion), and Simon Property Group Inc ($1.88 billion). View all of the most shorted stocks.

What does it mean to sell short Abbott Laboratories stock?

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. Abbott Laboratories' stock is trading down $2.43 today. To short Abbott Laboratories stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Abbott Laboratories will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abbott Laboratories?

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

How often is Abbott Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is September, 30 2020.


This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.